Abstract | BACKGROUND: The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene has been variably associated with insulin resistance, obesity and type 2 diabetes in several populations. However, this association has not been studied in Iranian subjects and we hypothesized that this variation might be associated with insulin resistance, type 2 diabetes and related metabolic traits in this population. METHODS: The Pro12Ala genotypes were determined by PCR-restriction fragment length polymorphism in 696 unrelated subjects including 412 non-diabetic controls and 284 type 2 diabetic patients. RESULTS: The frequency of the Ala allele was 9.4% and 5.9% in controls and type 2 diabetic subjects, respectively [adjusted odds ratio (OR) 0.457, p=0.005]. The Ala allele did not show a significant effect on anthropometric and biochemical parameters in the type 2 diabetic group, whereas in non-diabetic subjects, carriers of the Ala allele had significantly lower fasting insulin (p=0.007) and homeostasis model assessment of insulin resistance (HOMA-IR) (p=0.009) levels compared to Pro/Pro subjects. Multivariate logistic regression analysis showed that Pro12Ala polymorphism was an independent determinant of type 2 diabetes in this population. CONCLUSIONS:
|
Authors | Reza Meshkani, Mohammad Taghikhani, Bagher Larijani, Yadollah Bahrami, Shohreh Khatami, Ehteram Khoshbin, Amir Ghaemi, Sedigheh Sadeghi, Fatemeh Mirkhani, Azam Molapour, Khosrow Adeli |
Journal | Clinical chemistry and laboratory medicine
(Clin Chem Lab Med)
Vol. 45
Issue 4
Pg. 477-82
( 2007)
ISSN: 1434-6621 [Print] Germany |
PMID | 17439324
(Publication Type: Journal Article)
|
Chemical References |
- DNA Primers
- PPAR gamma
- Proline
- Alanine
|
Topics |
- Alanine
(genetics)
- Base Sequence
- DNA Primers
- Diabetes Mellitus, Type 2
(genetics)
- Genetic Predisposition to Disease
- Humans
- Insulin Resistance
(genetics)
- Iran
- PPAR gamma
(genetics)
- Polymorphism, Genetic
- Proline
(genetics)
|